Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Improving older women's knowledge and confidence to present early with breast symptoms: a randomised controlled trial of a radiographer-delivered intervention
Source of recordUK Trials
ISRCTNISRCTN31994827
Date ISRCTN assigned03/10/2007
Local reference number(s)N/A
Public titleImproving older women's knowledge and confidence to present early with breast symptoms: a randomised controlled trial of a radiographer-delivered intervention
Scientific title
AcronymPEP (Promoting Early Presentation)
Disease/condition/study domainBreast cancer
Study hypothesisThe supplementation of optimised usual care with one of two variants of a radiographer-delivered psycho-education intervention will be more effective than optimised usual care alone in improving women's knowledge and confidence to present promptly with breast symptoms.
Design/methodologyThree-arm multicentre randomised controlled trial
Research ethics reviewApproval received from King's College Hospital Research Ethics Committee on the 18th April 2007 (LREC Ref: 07/Q0703/51).
Countries of trialUnited Kingdom
Participants - inclusion criteriaWomen aged 67 - 70 years attending National Health Service (NHS) breast screening clinics for final routine mammography.
Participants - exclusion criteria1. Any significant disease or disorder that affects ability to consent or participate
2. Insufficient understanding of the English language, or language difficulties
3. Participant going overseas during the six-month study period
Patient information material
Anticipated start date30/07/2007
Anticipated end date30/10/2008
Status of trialOngoing
Target number of participants714
InterventionsAll three groups will receive optimised usual care, i.e., a reminder that they are no longer eligible for routine breast screening but may continue to request further breast screening themselves every three years. One group in addition will receive a radiographer-delivered booklet containing educational messages designed to increase women's knowledge and confidence to detect breast changes and to motivate them to present promptly if they discover a breast change. The third group will receive a 10-minute radiographer-delivered interview in addition to the booklet. The interview is based on the key messages of the booklet and provides the opportunity for the radiographer to reinforce and clarify the content of the booklet.

The intervention is given just once, duration 10 - 15 minutes for the interview group, 5 minutes or less for booklet-alone and optimised usual care. Follow up consists of a questionnaire sent at 1 month and another at 6 months post-intervention for all groups.
Primary outcome measure(s)Breast awareness, measured one month post-intervention, based on a composite measure of knowledge of non-lump breast cancer symptoms, knowledge of age-related relative risk and confidence to detect a breast change: each component (knowledge/risk/confidence) is given equal weighting and contributes one point to the total score (range 0 to 3), as follows:
1. Non-lump knowledge:
1.1. Score 1 if 5 - 9 symptoms identified
1.2. Score 0 if 0 - 4 symptoms identified
2. Relative risk:
2.1. Score 1 if identify old age group as most at risk
2.2. Score 0 if do not identify old age group as most at risk
3. Confidence:
3.1. Score 1 if check breasts at least once a week/month
3.2. Score 0 if check breasts at least once every six months or less
Secondary outcome measure(s)Secondary measures are changes at one month and six months post intervention in:
1. Knowledge of breast cancer symptoms (score 0 - 11)
2. Knowledge of relative risk (in the next year who is most likely to get breast cancer? [response categories: a 30 year old woman/a 50 year old woman/a 70 year old woman/a woman of any age])
3. Knowledge of absolute risk (how many women will develop breast cancer in their lifetime? [response categories: 1 in 3/1 in 9/1 in 100/1 in 1000])
4. Confidence to detect a breast change (how often do you check your breasts? [response categories: at least once a week/at least once a month/at least every six months/rarely or never])
5. Breast awareness, measured six months post intervention, based on a composite measure of knowledge of non-lump breast cancer symptoms, knowledge of age-related relative risk, and confidence to detect a breast change
PublicationsReview of evidence in: http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15992567
Sources of fundingCancer Research UK (UK)
Sponsor nameInstitute of Psychiatry (UK)
Sponsor detailsKings College London
De Crespigny Park
London
United Kingdom
SE5 8AF
Sponsor telephone+44 (0)20 7848 0675
Sponsor fax+44 (0)20 7848 0147
Sponsor emailgill.lambert@iop.kcl.ac.uk
Sponsor websitehttp://www.iop.kcl.ac.uk
Contact nameDr Caroline Burgess
Contact detailsCancer Research UK London Psychosocial Group
Adamson Centre
St Thomas' Hospital
London
United Kingdom
SE1 7EH
Contact telephone+44 (0)20 7188 0908
Contact fax+44 (0)20 7188 0905
Contact emailcaroline.burgess@kcl.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN31994827
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central